Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Roxane Laboratories, Inc. v. Camber Pharmaceuticals, Inc. et al
Case Number:
2:14-cv-04042
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 22, 2017
Roxane Owes $2M In Attys' Fees In 'Exceptional' Patent Row
A New Jersey federal judge has ordered Roxane Laboratories Inc. to pay $2 million in legal fees in a patent infringement claim against two generic-drug makers over a kidney medication, a ruling that follows the jurist's previous declaration that the case was "exceptional" for its lack of a legal basis.
-
April 12, 2017
Roxane Could Owe $2M After Patent Row Ruled 'Exceptional'
Roxane Laboratories Inc. could be on the hook for upward of $2 million in legal fees, after a New Jersey federal judge decided Wednesday the infringement claim it brought against two generic-drug makers over a kidney medication patent was unreasonable.
-
August 07, 2014
Roxane Loses Bid To Block Hetero's Generic Kidney Drug
A New Jersey federal judge on Wednesday gave the red light to Roxane Laboratories Inc.'s bid to block subsidiaries of Hetero Drugs Ltd. from manufacturing and marketing calcium acetate, a generic version of the kidney medication PhosLo, finding the subsidiaries’ version of the drug likely doesn’t infringe on Roxane’s patent.